Several grants focused on gender-related research at the University of Michigan in Ann Arbor are facing termination, according to federal authorities. The grants, totaling over $2.6 million from the National Institute of Health, cover topics such as HIV prevention in transgender women, cancer-related health disparities among gender minorities, and addressing bias and racism in healthcare. These cuts are the latest in a series of federal spending reductions under President Trump’s administration, targeting diversity, equity, and inclusion initiatives in higher education.
The affected research projects include studies on reproductive consequences of steroid hormone administration, couples-based HIV prevention for transgender women and their partners, violence and viral suppression among men living with HIV, and smoking-related outcomes among sexual and gender minorities. These projects are led by researchers like Dr. Molly Moravek, who focuses on transgender care and the long-term effects of hormone therapy on reproductive health, and Erin Kahle, who studies the connection between HIV and intimate partner violence.
The University of Michigan and the affected research projects have not yet provided comments on the funding terminations. The cancellation of these grants raises concerns about the future of gender-related research at the university and the impact on ongoing studies. The grants’ termination could hinder progress in understanding and addressing health disparities among marginalized communities, highlighting the importance of funding for gender-related research in academia.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
